JS Capital Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,100
Closed -$874K 117
2021
Q1
$874K Buy
+3,100
New +$887K 0.05% 53

Other funds holding WST

JS Capital Management's WST Position: Q2 2021 in Review

JS Capital Management sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 3,100 shares — an estimated $874K sold.

JS Capital Management first reported a position in WST in Q1 2021 and held it in 1 quarter. The position peaked at $874K in Q1 2021. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • JS Capital Management reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • JS Capital Management sold 3,100 West Pharmaceutical shares in Q2 2021, an estimated $874K.
  • JS Capital Management first reported a position in West Pharmaceutical in Q1 2021 and held it in 1 quarter.
  • JS Capital Management's West Pharmaceutical position peaked at $874K in Q1 2021.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on JS Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.